Future Biosimilars: Upcoming Patent Expirations and Market Entry Guide
- Garrett Sorenson
- 4 06 2026 Medication Guides
Explore the upcoming wave of biosimilar drug entries as major patents for Keytruda, Eylea, and others expire. Learn about cost savings, approval processes, and market trends shaping healthcare in 2026 and beyond.